HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Tannapfel Selected Research

Tumor Suppressor Protein p14ARF (p14ARF)

8/2004INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma.
1/2003Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck.
11/2002Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
9/2002Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
8/2002Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
8/2002INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
2/2002Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Tannapfel Research Topics

Disease

96Neoplasms (Cancer)
05/2022 - 01/2002
20Adenocarcinoma
01/2021 - 01/2004
19Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 07/2005
16Carcinoma (Carcinomatosis)
10/2019 - 08/2002
10Neoplasm Metastasis (Metastasis)
01/2021 - 10/2004
9Mesothelioma
01/2018 - 09/2009
9Ischemia
11/2007 - 06/2002
8Lung Neoplasms (Lung Cancer)
05/2021 - 07/2005
8Adenoma (Adenomas)
01/2020 - 11/2002
8Fibrosis (Cirrhosis)
06/2018 - 04/2002
8Hepatocellular Carcinoma (Hepatoma)
01/2012 - 01/2002
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 05/2002
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 05/2006
7Inflammation (Inflammations)
02/2019 - 04/2003
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 02/2009
6Breast Neoplasms (Breast Cancer)
05/2021 - 11/2005
6Melanoma (Melanoma, Malignant)
12/2017 - 12/2003
6Pancreatitis
12/2016 - 07/2003
6Squamous Cell Carcinoma of Head and Neck
11/2009 - 05/2002
5Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2012
5Occupational Diseases (Occupational Disease)
05/2021 - 01/2011
5Chronic Pancreatitis
01/2020 - 01/2004
5Sarcoma (Soft Tissue Sarcoma)
01/2014 - 12/2003
5Cholangiocarcinoma
02/2010 - 08/2002
5Carcinogenesis
01/2008 - 08/2002
4Prostatic Neoplasms (Prostate Cancer)
11/2021 - 04/2010
4Urinary Bladder Neoplasms (Bladder Cancer)
05/2021 - 01/2018
4Ovarian Neoplasms (Ovarian Cancer)
05/2021 - 03/2011
4Microsatellite Instability
01/2021 - 08/2003
4Wounds and Injuries (Trauma)
09/2019 - 01/2004
4Colitis
07/2019 - 11/2006
4Malignant Mesothelioma
09/2012 - 10/2009
4Hepatitis C
08/2008 - 08/2005
4Reperfusion Injury
01/2004 - 06/2002
3Pancreatic Fistula (Pancreatic Fistulas)
02/2022 - 05/2015
3Pulmonary Edema
01/2017 - 04/2003
3Klatskin Tumor
11/2015 - 06/2003
3Pathologic Constriction (Stenosis)
11/2015 - 01/2009
3Disease Progression
10/2015 - 09/2006
3Lymphatic Metastasis
11/2010 - 05/2006
3Infections
08/2006 - 02/2002
3Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2006 - 08/2004
3Aneuploidy (Aneuploid)
07/2006 - 05/2003
3Pleomorphic Adenoma
01/2003 - 11/2002

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
05/2021 - 02/2002
22Biomarkers (Surrogate Marker)IBA
07/2020 - 01/2002
21DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2002
12AsbestosIBA
05/2021 - 10/2009
11Messenger RNA (mRNA)IBA
01/2018 - 01/2002
10Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 10/2004
9MicroRNAs (MicroRNA)IBA
12/2018 - 10/2008
7Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 03/2011
7Tumor Suppressor Protein p14ARF (p14ARF)IBA
08/2004 - 02/2002
6Bevacizumab (Avastin)FDA Link
12/2018 - 01/2008
6Protein Isoforms (Isoforms)IBA
06/2018 - 11/2002
6ParaffinIBA
01/2018 - 01/2004
6EnzymesIBA
08/2004 - 08/2002
5Pharmaceutical PreparationsIBA
07/2019 - 08/2006
5Biological ProductsIBA
01/2019 - 01/2002
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 01/2004
5Formaldehyde (Formol)FDA Link
01/2018 - 01/2004
5Endothelin A ReceptorIBA
03/2007 - 03/2003
5Cyclin-Dependent Kinase Inhibitor p16IBA
08/2004 - 02/2002
4Circulating Tumor DNAIBA
01/2022 - 01/2017
4Leucovorin (Folinic Acid)FDA Link
01/2021 - 10/2015
4Peptides (Polypeptides)IBA
01/2021 - 11/2005
4Small Interfering RNA (siRNA)IBA
09/2019 - 10/2006
4Phosphotransferases (Kinase)IBA
11/2018 - 12/2003
4Capecitabine (Xeloda)FDA Link
12/2016 - 03/2011
4Antiviral Agents (Antivirals)IBA
08/2015 - 09/2006
4CarcinogensIBA
01/2012 - 01/2002
4RNA (Ribonucleic Acid)IBA
10/2008 - 08/2005
4Ribavirin (Virazole)FDA LinkGeneric
08/2008 - 08/2005
3AntibodiesIBA
01/2021 - 02/2002
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 08/2006
3AntigensIBA
12/2020 - 07/2003
3Insulin (Novolin)FDA Link
01/2020 - 02/2009
3Tumor Biomarkers (Tumor Markers)IBA
12/2018 - 07/2003
3ORALIT (ORS)IBA
11/2018 - 01/2018
3CytokinesIBA
11/2018 - 08/2003
3Cisplatin (Platino)FDA LinkGeneric
12/2016 - 09/2007
3Glucose (Dextrose)FDA LinkGeneric
11/2016 - 02/2009
3Anti-Bacterial Agents (Antibiotics)IBA
10/2013 - 06/2008
3Glutamic Acid (Glutamate)FDA Link
09/2012 - 12/2003
3Codon (Codons)IBA
08/2012 - 05/2006
3Cyclin D1IBA
03/2012 - 04/2006
3Interferon-alpha2bIBA
12/2007 - 08/2005
2IpilimumabIBA
05/2022 - 12/2017
2NivolumabIBA
05/2022 - 12/2017

Therapy/Procedure

41Therapeutics
02/2022 - 01/2002
18Drug Therapy (Chemotherapy)
01/2021 - 01/2002
7Liver Transplantation
01/2012 - 10/2004
6Neoadjuvant Therapy
05/2022 - 01/2008
4Photochemotherapy (Photodynamic Therapy)
11/2015 - 06/2003
4Lasers (Laser)
11/2015 - 10/2003
3Radiotherapy
02/2022 - 01/2018
3Pancreatectomy
02/2022 - 04/2008
3Immunotherapy
03/2019 - 04/2010
3Pancreaticoduodenectomy
05/2015 - 06/2003
3Pancreas Transplantation
02/2009 - 06/2002